Please use this identifier to cite or link to this item:
|Title:||Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA||Authors:||González, A.
Espinosa Angarica, V.
|Issue Date:||2019||Publisher:||Nature Publishing Group||Citation:||González, A., Salillas, S., Velázquez-Campoy, A., Espinosa Angarica, V., Fillat, M.F., Sancho, J., Lanas, Á. (2019). Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA. Scientific Reports 9 (1) : 11294. ScholarBank@NUS Repository. https://doi.org/10.1038/s41598-019-47746-9||Rights:||Attribution 4.0 International||Abstract:||The increasing antibiotic resistance evolved by Helicobacter pylori has alarmingly reduced the eradication rates of first-line therapies. To overcome the current circulating resistome, we selected a novel potential therapeutic target in order to identify new candidate drugs for treating H. pylori infection. We screened 1120 FDA-approved drugs for molecules that bind to the essential response regulator HsrA and potentially inhibit its biological function. Seven natural flavonoids were identified as HsrA binders. All of these compounds noticeably inhibited the in vitro DNA binding activity of HsrA, but only four of them, apigenin, chrysin, kaempferol and hesperetin, exhibited high bactericidal activities against H. pylori. Chrysin showed the most potent bactericidal activity and the most synergistic effect in combination with clarithromycin or metronidazole. Flavonoid binding to HsrA occurs preferably at its C-terminal effector domain, interacting with amino acid residues specifically involved in forming the helix-turn-helix DNA binding motif. Our results validate the use of HsrA as a novel and effective therapeutic target in H. pylori infection and provide molecular evidence of a novel antibacterial mechanism of some natural flavonoids against H. pylori. The results further support the valuable potential of natural flavonoids as candidate drugs for novel antibacterial strategies. © 2019, The Author(s).||Source Title:||Scientific Reports||URI:||https://scholarbank.nus.edu.sg/handle/10635/211659||ISSN:||2045-2322||DOI:||10.1038/s41598-019-47746-9||Rights:||Attribution 4.0 International|
|Appears in Collections:||Elements|
Show full item record
Files in This Item:
|10_1038_s41598-019-47746-9.pdf||2.26 MB||Adobe PDF|
checked on Sep 30, 2022
checked on Oct 6, 2022
This item is licensed under a Creative Commons License